Physician
Radiation Oncology
Dr. Mark B. Hazuka, MD
|
|
Give Review
Mark Hazuka practices Radiation Oncology. He went to medical school at Creighton University School of Medicine. Creighton University School of Medicine has a rank of 79 in research and a 78 in primary care He received 7 awards: "CMS Meaningful Use Stage 1 Certification", "The Best Doctors in America: Central Region", "The Best Doctors in America", "ASTRO Travel Grant Award", "Pi Mu Epsilon", "Superior Scholastic Achievement Citation" and "Presidential Nomination". Mark Hazuka has written publications. He has 28 publications published with PubMed. The lastest paper is: 'Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer.' He is registered with Medicare and accepts Medicare payments.
Publications
- Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergrou...
- Controversies in the nonsurgical treatment of stage III non-small cell lung cancer.
- Mediastinoscopy incisional metastasis. A radiotherapeutic approach.
- Survival results in adult patients treated for medulloblastoma.
- AIDS-related non-Hodgkin's lymphoma: the outcome and efficacy of radiation therapy.
- Beta-carotene induces morphological differentiation and decreases adenylate cyclase activity in melanoma cells in culture.
- Treatment-related central nervous system toxicity: MR imaging evaluation with CT and clinical correlation.
- Brain metastases: results and effects of re-irradiation.
- Hip prostheses during pelvic irradiation: effects and corrections.
- Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III ra...
- Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest On...
- Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis.
- Results of primary and adjuvant CT-based 3-dimensional radiotherapy for malignant tumors of the paranasal sinuses.
- Use of Veff and iso-NTCP in the implementation of dose escalation protocols.
- Preservation of parotid function after external beam irradiation in head and neck cancer patients: a feasibility study using 3-dimensional treatment planning.
- Spinal cord ependymomas treated with surgery and radiation therapy. A review of 11 cases.
- The evolving role of radiation therapy in the treatment of locally advanced lung cancer.
- Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysis.
- Prostatic thermoluminescent dosimeter analysis in a patient treated with 18 MV X rays through a prosthetic hip.
- Multiple brain metastases are associated with poor survival in patients treated with surgery and radiotherapy.
- Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology ...
- Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer.
- Dose escalation for non-small cell lung cancer using conformal radiation therapy.
- Dose-volume complication analysis for visual pathway structures of patients with advanced paranasal sinus tumors.
- Volume and dose parameters for survival of non-small cell lung cancer patients.
- Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer.
- Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients.
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- The Best Doctors in America: Central Region
- The Best Doctors in America
- ASTRO Travel Grant Award
- Pi Mu Epsilon
- Superior Scholastic Achievement Citation
- Presidential Nomination
Education
-
Creighton University School of Medicine -
Creighton University
Drug Facts
| NPI NUMBER | 1750361259 | |
| NPPES Provider LastName | HAZUKA | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 891131982 | |
| NPPES Provider State | NV | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 43.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1750361259 |
| Last Name Of The Provider | HAZUKA |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
Dr. Andrew S. Tanner, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Barry L. Gardner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jane W. Ridings, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alan T. Monroe, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Anuj V. Peddada, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John E. Schiller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul A. Mitchell, MD |